Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colitis, Ulcerative × Mesalamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Lymphoma, Follicular 1 Colorectal Neoplasms 1 Colitis, Ulcerative 1

Interventions

etrolizumab 4 Infliximab 3 peficitinib 1 golimumab 1 NX-13 1 Methylprednisolone 1 Mesalamine 1 Injections 1 CT-P13 1 Andrographis paniculata extract 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02093663 2021-06-09

PACE

Takeda

Phase 3 Completed

107 enrolled 18 charts

Colitis, Ulcerative, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡